Showing results (441-450 of 571) with videos related to
Sort By:
Pageof 58
Oncology|October 2, 2004
Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-upS Barni, E Piazza, L Frontini, et al.Breast (Edinburgh, Scotland)|March 10, 2023
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trialsLaura Pala, Tommaso De Pas, Eleonora Pagan, et al.Frontiers in Microbiology|August 31, 2018
Autophagic Induction Greatly Enhances Leishmania major Intracellular Survival Compared to Leishmania amazonensis in CBA/j-Infected MacrophagesBeatriz R S Dias, Carina S de Souza, Niara de Jesus Almeida, et al.International Journal of Obesity (2005)|May 2, 2007
Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic miceA G Salerno, T R Silva, M E C Amaral, et al.Frontiers in Bioscience (Landmark Edition)|December 29, 2015
Higher cardiogenic potential of iPSCs derived from cardiac versus skin stromal cellsViviana Meraviglia, Jianyan Wen, Luca Piacentini, et al.Plos One|July 27, 2011
Histone deacetylase inhibition enhances self renewal and cardioprotection by human cord blood-derived CD34 cellsIlaria Burba, Gualtiero I Colombo, Lidia Irene Staszewsky, et al.Journal of Inorganic Biochemistry|November 4, 2004
The [Ru(Hedta)NO](0.1-) system: structure, chemical reactivity and biological assaysPatrícia Graça Zanichelli, Alexandre M Miotto, Heder F G Estrela, et al.ESMO Gastrointestinal Oncology|April 17, 2026
Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069]A Gandini, V Martelli, L Belgioia, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancerA Gandini, V Martelli, L Belgioia, et al.Neuropathology and Applied Neurobiology|June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)M Ripolone, R Violano, D Ronchi, et al.Pageof 58